Oncology

Check out this week’s highlights on dvm360.com.

The importance of research on GI lymphoma and IBD and how to participate in the Basepaws study

Exploring the differences between traditional chemotherapy and targeted therapy

Marks 13th annual pet cancer campaign led by Petco Love in partnership with Blue Buffalo

Jaguar Animal Health’s crofelemer product has conditional approval from the FDA

The CANcer Detection in Dogs (CANDiD) study demonstrates the performance of the novel liquid biopsy OncoK9 and sets a new benchmark for veterinary medicine.

Craig A. Clifford, DVM, MS, DACVIM (Oncology), offered an overview of the latest treatment and diagnostic tools accelerating veterinary oncology

Learn key hospital design protocols to help protect patients and staff

Tumor cells and metabolites can be shed into the urine and these molecules may be used for tumor detection.

This marks the first study designed to examine pet exposure to aromatic amines in the household.

An experienced clinician discusses the road to success when the diagnostic path is unclear.

Investigators with pet health insurer Nationwide examined claims for 1.6 million dogs

Here's our regular rundown of new and notable veterinary products.

The gift will expand the OFA's support of educational grants through CHF's Clinician-Scientist Fellowship Program.

The resource was designed to enhance pet parents’ knowledge surrounding veterinary oncology.

3 videos featuring tips and tricks for treating canine and feline patients with lymphoma.

Crofelemer (Canalevia-CA1) is conditionally approved by the FDA for treatment of chemotherapy-induced diarrhea in dogs and could also be used to treat exercise-induced diarrhea.

The BluePearl Greater Philadelphia network hospitals are offering a funded study evaluating the first-in-class liquid biopsy test from PetDx in 2022.

The study analyzed canine cancer in over 700 dogs across 23 tumor types and can help progress precision cancer therapeutics.

The collaboration will provide IDEXX Reference Laboratories’ veterinary customers access to FidoCure Next Generation DNA Sequencing Test.

In a dvm360® interview, Sue Ettinger, DVM, DACVIM (Oncology), reviewed different variables that may put felines at risk of developing gastrointestinal lymphoma.

At a recent webinar, oncology specialist Dr. Philip Bergman offered his top 10 list of advances that could make a difference for your next cancer patient. (Sponsored by VCA Animal Hospitals)

The collaborative effort makes OncoK9 liquid biopsy available immediately to more veterinary customers

In a dvm360® interview, Sue Ettinger, DVM, DACVIM (Oncology), highlighted discrepancies among dog and cat patients when treating lymphoma with chemotherapy.

In this episode of The Vet Blast Podcast, Adam Christman, DVM, MBA, is joined by Barbara Powers, DVM, DACVP, and Barbara E. Kitchell, DVM, PhD, DACVIM to discuss the various types of cancer diagnostics including genomic sequencing and targeted treatments methods. (Supported by VCA Animal Hospital)